| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.34 | 0.05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |